insights_auto
Why is GERN down 2.72%?
Dive Deeperchevron_right
GERN:NASDAQ
Geron Corp
$0.97
arrow_downward
-2.72%(-0.027) 1D
$0.96
arrow_downward
-0.72% (-0.0070)bedtimeAfter hours
Closed: Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GERN...
Open
$0.99
High
$0.99
Low
$0.95
Mkt. cap
625.50M
Avg. vol.
14.50M
Volume
7.10M
52-wk high
$2.01
52-wk low
$0.84
EPS
-$0.07
Beta
0.62
Shares outstanding
644.24M
No. of employees
258
Open
$0.99
High
$0.99
Low
$0.95
Mkt. cap
625.50M
Avg. vol.
14.50M
Volume
7.10M
52-wk high
$2.01
52-wk low
$0.84
EPS
-$0.07
Beta
0.62
Shares outstanding
644.24M
No. of employees
258
News stories
From web sources and news partners
Investing.com
·
3 days ago
Geron at Stifel 2026 Healthcare Conference: RYTELO gains traction
Profile
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
About Geron Corp
CEOJohn A Scarlett
Employees258
Founded1990
HeadquartersMenlo Park, California, United States
SectorHealth Care
IndustryBiotechnology
Websitegeron.com